Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-11 00:00 | 2024-01-09 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $631.81 | 34,538 | $21,821,412 | 99,719,884 | 0.0% |
| 2024-01-05 22:15 | 2024-01-04 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $630.28 | 14,388 | $9,068,446 | 99,754,422 | 0.0% |
| 2023-11-07 00:25 | 2023-11-06 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $571.10 | 670 | $382,637 | 4,708 | -12.5% |
| 2023-10-12 23:00 | 2023-10-11 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $605.44 | 215,000 | $130,169,880 | 99,768,810 | -0.2% |
| 2023-09-13 23:14 | 2023-09-12 | LLY | ELI LILLY & Co | Weems Alonzo | Officer; EVP, ERM & CECO | Pharmaceutical Preparations | SALE | $590.98 | 1,148 | $678,445 | 7,760 | -12.9% |
| 2023-09-08 23:00 | 2023-09-07 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $571.41 | 210,000 | $119,995,281 | 99,983,810 | -0.2% |
| 2023-09-01 23:00 | 2023-08-31 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $554.81 | 46,541 | $25,821,608 | 100,193,810 | 0.0% |
| 2023-08-31 23:00 | 2023-08-30 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $555.32 | 6,181 | $3,432,417 | 100,240,351 | 0.0% |
| 2023-08-30 23:00 | 2023-08-29 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $554.10 | 28,747 | $15,928,698 | 100,246,532 | 0.0% |
| 2023-08-29 23:00 | 2023-08-28 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $546,751.75 | 37,660 | $20,590,670,931 | 100,275,279 | 0.0% |
| 2023-08-28 23:00 | 2023-08-25 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $554.38 | 63,572 | $35,243,236 | 100,312,939 | -0.1% |
| 2023-08-25 23:00 | 2023-08-24 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $554.74 | 20,992 | $11,645,029 | 100,376,511 | 0.0% |
| 2023-08-24 23:00 | 2023-08-23 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $555.69 | 1,307 | $726,284 | 100,397,503 | 0.0% |
| 2023-08-22 23:34 | 2023-08-21 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $546.51 | 600 | $327,906 | 5,378 | -10.0% |
| 2023-08-16 23:00 | 2023-08-15 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $543.72 | 50,222 | $27,306,746 | 100,398,810 | 0.0% |
| 2023-08-15 23:00 | 2023-08-14 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $539.08 | 164,778 | $88,829,249 | 100,449,032 | -0.2% |
| 2023-08-14 23:00 | 2023-08-11 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $528.50 | 83,039 | $43,886,427 | 100,613,810 | -0.1% |
| 2023-08-11 22:50 | 2023-08-10 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $528.14 | 3,000 | $1,584,405 | 100,696,849 | 0.0% |
| 2023-08-10 23:00 | 2023-08-09 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $528.83 | 123,961 | $65,554,320 | 100,699,849 | -0.1% |
| 2023-08-10 00:10 | 2023-08-08 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $523.74 | 204,409 | $107,056,413 | 100,823,810 | -0.2% |
| 2023-07-24 22:55 | 2023-07-21 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $466.62 | 591 | $275,773 | 101,028,219 | 0.0% |
| 2023-07-03 19:00 | 2023-06-30 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $467.60 | 164,125 | $76,744,390 | 101,028,810 | -0.2% |
| 2023-06-30 22:00 | 2023-06-29 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $465.08 | 44,115 | $20,517,137 | 101,192,935 | 0.0% |
| 2023-06-30 16:06 | 2023-06-28 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $465.41 | 11,760 | $5,473,169 | 101,237,050 | 0.0% |
| 2023-06-23 18:27 | 2023-06-22 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $459.28 | 107,022 | $49,153,578 | 101,248,810 | -0.1% |
| 2023-06-22 20:06 | 2023-06-21 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $454.13 | 31,454 | $14,284,312 | 101,355,832 | 0.0% |
| 2023-06-21 22:13 | 2023-06-20 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $454.08 | 34,156 | $15,509,556 | 101,387,286 | 0.0% |
| 2023-06-20 20:26 | 2023-06-16 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $455.50 | 25,015 | $11,394,292 | 101,421,442 | 0.0% |
| 2023-06-16 22:58 | 2023-06-15 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $454.15 | 27,353 | $12,422,247 | 101,446,457 | 0.0% |
| 2023-06-15 23:21 | 2023-06-14 | LLY | ELI LILLY & Co | Norton Johna | Officer; EVP, Global Quality | Pharmaceutical Preparations | SALE | $446.15 | 3,294 | $1,469,602 | 30,114 | -9.9% |
| 2023-06-02 23:29 | 2023-06-01 | LLY | ELI LILLY & Co | Jonsson Patrik | Officer; EVP&Pres, LLY Imm, LLY USA&CCO | Pharmaceutical Preparations | SALE | $429.46 | 6,000 | $2,576,760 | 36,941 | -14.0% |
| 2023-05-22 19:01 | 2023-05-19 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $442.62 | 194,354 | $86,024,248 | 101,473,810 | -0.2% |
| 2023-05-16 23:31 | 2023-05-15 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $435.29 | 600 | $261,174 | 5,978 | -9.1% |
| 2023-05-15 20:01 | 2023-05-12 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $442.77 | 20,646 | $9,141,436 | 101,668,164 | 0.0% |
| 2023-05-04 21:30 | 2023-05-03 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $426.40 | 178,302 | $76,028,739 | 101,688,810 | -0.2% |
| 2023-05-03 22:13 | 2023-05-02 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $409.75 | 41,698 | $17,085,593 | 101,867,112 | 0.0% |
| 2023-05-01 21:32 | 2023-04-28 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $398.48 | 225,000 | $89,657,663 | 101,908,810 | -0.2% |
| 2023-04-07 18:38 | 2023-04-06 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $367.27 | 130,297 | $47,853,827 | 102,133,810 | -0.1% |
| 2023-04-06 20:21 | 2023-04-05 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $363.37 | 69,703 | $25,327,916 | 102,264,107 | -0.1% |
| 2023-04-04 18:53 | 2023-04-03 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $350.49 | 210,000 | $73,603,593 | 102,333,810 | -0.2% |
| 2023-04-03 17:25 | 2023-03-31 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $342.01 | 205,000 | $70,111,866 | 102,543,810 | -0.2% |
| 2023-03-27 17:31 | 2023-03-24 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $335.82 | 200,000 | $67,164,560 | 102,748,810 | -0.2% |
| 2023-03-13 23:31 | 2023-03-10 | LLY | ELI LILLY & Co | Weems Alonzo | Officer; EVP, ERM & CECO | Pharmaceutical Preparations | SALE | $318.85 | 1,000 | $318,850 | 8,908 | -10.1% |
| 2023-03-02 00:31 | 2023-02-27 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $322.47 | 600 | $193,482 | 6,578 | -8.4% |
| 2023-02-15 01:12 | 2023-02-10 | LLY | ELI LILLY & Co | White Anne E. | Officer; EVP & Pres, Lilly Neuroscience | Pharmaceutical Preparations | SALE | $344.62 | 5,000 | $1,723,075 | 57,926 | -7.9% |
| 2022-12-05 20:15 | 2022-12-02 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $372.88 | 49,089 | $18,304,193 | 102,948,810 | 0.0% |
| 2022-12-02 19:29 | 2022-12-01 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $371.54 | 160,911 | $59,785,500 | 102,997,899 | -0.2% |
| 2022-11-08 21:45 | 2022-11-07 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $363.94 | 63,585 | $23,141,042 | 103,158,810 | -0.1% |
| 2022-11-07 22:34 | 2022-11-04 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $363.77 | 1,336 | $485,996 | 103,222,395 | 0.0% |
| 2022-11-04 19:21 | 2022-11-03 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $362.08 | 133,948 | $48,499,892 | 103,223,731 | -0.1% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.